WASHINGTON -A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis ...

By Blake Brittain WASHINGTON - A Washington, D.C. federal judge on Wednesday refused Novartis' eleventh-hour bid to block ...

The Federal Circuit reversed a Delaware district court’s 2023 ruling axing a Novartis Pharmaceuticals Corp. patent covering ...

(RTTNews) - Swiss drug major Novartis (NVS) Monday announced that the US Court of Appeals for the Federal Circuit or CAFC has decided to upheld the validity of the Entresto (sacubitril/valsartan) ...

Analyst Graham Parry from Bank of America Securities maintained a Hold rating on Novartis AG (NOVN – Research Report) and decreased the price ...

Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. | ...

Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

Difficult economic conditions and persistently weak demand for many products have forced companies across Europe to freeze ...

Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator ...

Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 2,066.37 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.